Hypoglycemic News and Research

RSS
Inhaled corticosteroids may cause diabetes

Inhaled corticosteroids may cause diabetes

Optivia, UCSF receive SBIR grant to develop transporter-based assay system

Optivia, UCSF receive SBIR grant to develop transporter-based assay system

Biodel reports data on Linjeta formulation for type 1 diabetes at Technology Meeting in Bethesda

Biodel reports data on Linjeta formulation for type 1 diabetes at Technology Meeting in Bethesda

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

AACE publishes consensus statement for continuous glucose monitoring

AACE publishes consensus statement for continuous glucose monitoring

Phase 3 clinical study demonstrates efficacy of metformin therapy in type 2 diabetes

Phase 3 clinical study demonstrates efficacy of metformin therapy in type 2 diabetes

Over one in three diabetics do not take insulin as prescribed

Over one in three diabetics do not take insulin as prescribed

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Annals of Internal Medicine publishes GRACE study data on HIV therapy

New implantable sensor to continuously monitor tissue glucose

New implantable sensor to continuously monitor tissue glucose

Generex reports positive trends in ongoing Oral-lyn buccal insulin spray global Phase III trial

Generex reports positive trends in ongoing Oral-lyn buccal insulin spray global Phase III trial

Mismanagement of diabetes leads to fatal accident

Mismanagement of diabetes leads to fatal accident

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Tolerx initiates confirmatory Phase 3 clinical trial to evaluate otelixizumab in new-onset type 1 diabetes

Tolerx initiates confirmatory Phase 3 clinical trial to evaluate otelixizumab in new-onset type 1 diabetes

Final results of VIAject vs. RHI Phase 3 study in type 2 diabetes patients presented at 70th ADA

Final results of VIAject vs. RHI Phase 3 study in type 2 diabetes patients presented at 70th ADA

Phase 2b clinical trial data of SGLT2 inhibitor in patients with type 2 diabetes presented at ADA 2010

Phase 2b clinical trial data of SGLT2 inhibitor in patients with type 2 diabetes presented at ADA 2010

AFREZZA non-inferior to standard therapy insulin lispro in reducing HbA1c levels of Type 1 diabetics

AFREZZA non-inferior to standard therapy insulin lispro in reducing HbA1c levels of Type 1 diabetics

Medtronic launches iPro2 Professional CGM system to help improve diabetes management

Medtronic launches iPro2 Professional CGM system to help improve diabetes management

Preliminary outcomes and trends from Phase III pivotal study of Generex Oral-lyn reported

Preliminary outcomes and trends from Phase III pivotal study of Generex Oral-lyn reported

Diabetic patients with limited health literacy are at higher risk for hypoglycemia: Study

Diabetic patients with limited health literacy are at higher risk for hypoglycemia: Study